TY - JOUR
T1 - Added prognostic value of ischaemic threshold in radionuclide myocardial perfusion imaging
T2 - a common-sense integration of exercise tolerance and ischaemia severity
AU - Marini, Cecilia
AU - Acampa, Wanda
AU - Bauckneht, Matteo
AU - Daniele, Stefania
AU - Capitanio, Selene
AU - Cantoni, Valeria
AU - Fiz, Francesco
AU - Zampella, Emilia
AU - Dib, Bassam
AU - Assante, Roberta
AU - Bruzzi, Paolo
AU - Sambuceti, Gianmario
AU - Cuocolo, Alberto
PY - 2015
Y1 - 2015
N2 - Purpose: Reversible ischaemia at radionuclide myocardial perfusion imaging (MPI) accurately predicts risk of cardiac death and nonfatal myocardial infarction (major adverse cardiac events, MACE). This prognostic penetrance might be empowered by accounting for exercise tolerance as an indirect index of ischaemia severity. The present study aimed to verify this hypothesis integrating imaging assessment of ischaemia severity with exercise maximal rate pressure product (RPP) in a large cohort of patients with suspected or known coronary artery disease (CAD).Methods and results: We analysed 1,502 consecutive patients (1,014 men aged 59 ± 10 years) submitted to exercise stress/rest MPI. To account for exercise tolerance, the summed difference score (SDS) was divided by RPP at tracer injection providing a clinical prognostic index (CPI). Reversible ischaemia was documented in 357 patients (24 %) and was classified by SDS as mild (SDS 2–4) in 180, moderate (SDS 5–7) in 118 and severe (SDS >7) in 59. CPI values of ischaemic patients were clustered into tertiles with lowest and highest values indicating low and high risk, respectively. CPI modified SDS risk prediction in 119/357 (33 %) patients. During a 60-month follow-up, MACE occurred in 68 patients. Kaplan-Meier analysis revealed that CPI significantly improved predictive power for MACE incidence with respect to SDS alone. Multivariate Cox analysis confirmed the additive independent value of CPI-derived information.Conclusion: Integration of ischaemic threshold and ischaemia extension and severity can improve accuracy of exercise MPI in predicting long-term outcome in a large cohort of patients with suspected or known CAD.
AB - Purpose: Reversible ischaemia at radionuclide myocardial perfusion imaging (MPI) accurately predicts risk of cardiac death and nonfatal myocardial infarction (major adverse cardiac events, MACE). This prognostic penetrance might be empowered by accounting for exercise tolerance as an indirect index of ischaemia severity. The present study aimed to verify this hypothesis integrating imaging assessment of ischaemia severity with exercise maximal rate pressure product (RPP) in a large cohort of patients with suspected or known coronary artery disease (CAD).Methods and results: We analysed 1,502 consecutive patients (1,014 men aged 59 ± 10 years) submitted to exercise stress/rest MPI. To account for exercise tolerance, the summed difference score (SDS) was divided by RPP at tracer injection providing a clinical prognostic index (CPI). Reversible ischaemia was documented in 357 patients (24 %) and was classified by SDS as mild (SDS 2–4) in 180, moderate (SDS 5–7) in 118 and severe (SDS >7) in 59. CPI values of ischaemic patients were clustered into tertiles with lowest and highest values indicating low and high risk, respectively. CPI modified SDS risk prediction in 119/357 (33 %) patients. During a 60-month follow-up, MACE occurred in 68 patients. Kaplan-Meier analysis revealed that CPI significantly improved predictive power for MACE incidence with respect to SDS alone. Multivariate Cox analysis confirmed the additive independent value of CPI-derived information.Conclusion: Integration of ischaemic threshold and ischaemia extension and severity can improve accuracy of exercise MPI in predicting long-term outcome in a large cohort of patients with suspected or known CAD.
KW - Coronary artery disease
KW - Imaging
KW - Ischaemia
KW - Nuclear medicine
KW - Prognosis
UR - http://www.scopus.com/inward/record.url?scp=84925543153&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84925543153&partnerID=8YFLogxK
U2 - 10.1007/s00259-014-2963-8
DO - 10.1007/s00259-014-2963-8
M3 - Article
C2 - 25476258
AN - SCOPUS:84925543153
SN - 0340-6199
VL - 42
SP - 750
EP - 760
JO - European Journal of Pediatrics
JF - European Journal of Pediatrics
IS - 5
ER -